Boston Scientific Corp (BSX)

BSX on New York Consolidated

13.18USD
30 Oct 2014
Price Change (% chg)

$0.04 (+0.30%)
Prev Close
$13.14
Open
$13.12
Day's High
$13.22
Day's Low
$13.06
Volume
10,052,887
Avg. Vol
11,962,269
52-wk High
$14.08
52-wk Low
$11.10

BSX

Chart for BSX

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.03
Market Cap (Mil.): $17,419.80
Shares Outstanding (Mil.): 1,325.71
Dividend: --
Yield (%): --

Financials

  BSX Industry Sector
P/E (TTM): 60.80 41.93 34.41
EPS (TTM): 0.22 -- --
ROI: 1.93 6.89 17.37
ROE: 4.34 10.75 18.18
Search Stocks

UPDATE 3-Boston Scientific posts profit on heart device sales

Oct 22 - Boston Scientific Corp on Wednesday posted a third-quarter profit on increased sales of its implantable heart devices and raised its full-year revenue outlook, sending its shares up nearly 4 percent.

22 Oct 2014

Boston Scientific profit up on heart device sales

Oct 22 - Boston Scientific Corp on Wednesday posted a third-quarter profit in line with analysts' expectations on stronger sales of its key implantable heart devices.

22 Oct 2014

FDA panel offers mixed view on Boston Scientific Watchman device

WASHINGTON - An advisory panel to the U.S. Food and Drug Administration offered a mixed view of Boston Scientific Corp's Watchman heart device on Wednesday, concluding it is probably safe but not particularly effective in reducing the risk of stroke in patients with a certain type of irregular heart beat.

08 Oct 2014

FDA panel offers mixed view on Boston Scientific Watchman device

WASHINGTON, Oct 8 - An advisory panel to the U.S. Food and Drug Administration offered a mixed view of Boston Scientific Corp's Watchman heart device on Wednesday, concluding it is probably safe but not particularly effective in reducing the risk of stroke in patients with a certain type of irregular heart beat.

08 Oct 2014

Damages slashed to $34.6 million in Boston Scientific mesh trial

- A jury award of $73.4 million to a woman who said she was injured by a Boston Scientific Corp transvaginal mesh device has been cut to $34.6 million, thanks to a Texas law that caps how much companies must pay in punitive damages.

03 Oct 2014

Damages slashed to $34.6 mln in Boston Scientific mesh trial

Oct 3 - A jury award of $73.4 million to a woman who said she was injured by a Boston Scientific Corp transvaginal mesh device has been cut to $34.6 million, thanks to a Texas law that caps how much companies must pay in punitive damages.

03 Oct 2014

Court orders Boston Scientific to pay $308 million in damages to Mirowski

- Boston Scientific Corp said a U.S. court ruled that it breached its license agreement with Mirowski Family Ventures LLC and awarded Mirowski $308 million in damages.

24 Sep 2014

Court orders Boston Scientific to pay $308 mln in damages to Mirowski

Sept 24 - Boston Scientific Corp said a U.S. court ruled that it breached its license agreement with Mirowski Family Ventures LLC and awarded Mirowski $308 million in damages.

24 Sep 2014

Freshfields recruits veteran M&A partner from Shearman & Sterling

(This Sept. 15 story changes the 10th paragraph to reflect that Presser was not practicing law at Paine & Partners)

16 Sep 2014

Boston Scientific ordered to pay $73 million over mesh device

- A Texas jury has ordered Boston Scientific Corp to pay $73 million to a woman who said she suffered serious injuries from a transvaginal mesh device, the first loss for the device maker in one of thousands of suits over the products.

09 Sep 2014

Competitors

  Price Change
Abbott Laboratories (ABT.N) $43.49 +0.75
Medtronic, Inc. (MDT.N) $67.43 +0.39
St. Jude Medical, Inc. (STJ.N) $64.28 +2.38

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks